Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0KFRJ1
Fri, 03.02.2023
bioXXmed AG
Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres
Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai.
Centaur has increase [ … ]
Fri, 03.02.2023
bioXXmed AG
Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres
Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai.
Centaur has increase [ … ]
Thu, 30.09.2021
CytoTools AG
Annual General Meeting of CytoTools AG votes for dismissal of all Supervisory Board members
Darmstadt, 30 September 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, today held its Annual General Meeting in virtual form. Of the company's share capital of EUR 4,028,000.00, [ … ]
Thu, 30.09.2021
CytoTools AG
Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule
- Management Board members Dr. Freyberg and Dr. Kaiser not available for contract extensions after being voted out of office by the Supervisory Board
- Management Board contracts expire by rotation today
Darmstadt, 30 Septem [ … ]
Wed, 29.09.2021
CytoTools AG
CytoTools Reports Progress of DermaPro(R) Phase III Study in Europe and Provides Operational Status Update
- Good progress in patient recruitment for Phase III study despite unforeseen delays due to COVID-19
- Sales of Woxheal(R) gaining significant momentum since September
- Further development steps of DPOCL inhalation therapy suspended as a prec [ … ]
Tue, 29.06.2021
CytoTools AG
CytoTools cures resolution of 2020 Annual General Meeting with proposed capital increase
- Resolution on added items to the 2020 agenda proved to be unfeasible from a technical point of view
- Proposal to the 2021 Annual General Meeting is essentially the same as the resolution adopted in 2020
Darmstadt, 29 June 2021 - CytoTools AG (ISIN DE000A0KF [ … ]
Mon, 21.06.2021
CytoTools AG
CytoTools Q1 Trading Update: Treatment numbers in India slightly above previous quarter despite significant pandemic impact
- Over 10,000 use cases in Q1 despite tough lockdown in India
- Expansion into Africa following provisional approval of Woxheal in Kenya
Darmstadt, 21 June 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding comp [ … ]
Mon, 26.04.2021
CytoTools AG
CytoTools signs collaboration agreement to develop inhalation therapy for viral infections such as COVID-19 and influenza
- Cooperation with medical technology specialists for inhalative applications
- Regulatory approval with early out-licensing targeted
- Completion of further development steps planned by end of third quarter
Darmstadt, 26 April [ … ]
Mon, 21.12.2020
CytoTools AG
CytoTools receives confirmation of efficacy of DPCOL also against influenza viruses
- Virus-killing effect of DPOCL also confirmed with regard to influenza viruses
- Novel therapeutic approach thus also of high commercial interest beyond Corona pandemic
- Final results report on Sars-CoV-2 virus confirms efficacy of more than 95 percent
Darmstadt, [ … ]
Mon, 07.12.2020
CytoTools AG
Supervisory Board of CytoTools AG expresses trust in the Management Board after the Annual General Meeting
- More than 98 percent of the shareholders represented support the company's current strategy
- Shareholder group blocks large parts of the agenda with capital majority
- Objection of two shareholders against capital measure significantly belo [ … ]